Clinical Trial Update: Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing immunogenicity and safety of Sci-B-Vac® to Engerix-B® in adults with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• Sci-B-Vac (hepatitis B vaccine (recombinant))

Snippet

Sponsor: VBI Vaccines Inc. | Conditions: Hepatitis B Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2020-07-07